| abstract |
Methods for treating an ocular melanoma in a patient, e.g., uveal melanoma, comprising administering to the patient an effective amount of an antibody that binds galectin-9. Also provided herein are methods for identifying a subject as having the ocular melanoma based on the level of Galectin-9 in a biological sample (e.g., a blood sample) from a subject suspected of having the ocular melanoma. |